The healthcare overhaul has allowed 2.5 million young adults to gain insurance coverage under their parents' plans, a figure that is more than double previous estimates.
WASHINGTON-The healthcare overhaul has allowed 2.5 million young adults to gain insurance coverage under their parents' plans, a figure that is more than double previous estimates.
Health and Human Services Secretary Kathleen Sebelius says the increased coverage of 19- to 25-year-olds is directly attributable to the Patient Protection and Affordable Care Act's (PPACA) new dependent coverage provision that took effect in September 2010. Initial reports estimated 1 million young adults had gained coverage.
According to analysts, nearly 36% of those ages 19 to 25-about 10.5 million people-were uninsured in the third quarter of 2010. By the second quarter of 2011, just over 27% of them-or 8 million people-were uninsured.
Young adults represent the largest group of uninsured people, and they have the lowest rate of access to employer-based insurance, according to a White House document. While they don't typically require expensive procedures, one in six young adults has a chronic illness such as cancer, diabetes or asthma, the report states.
Previously, young adults who attended college full time were eligible to remain on their parents' plan. However, questions arose about how to define a full-time student.
"What if they're only there one hour a week and working 40 hours a week at the loading dock," Keckley says.
Under PPACA, young adults can work full time and elect not to participate in their employers' plan in favor of remaining on their parents' family plan. They also are eligible even if they are married and living elsewhere.
Benefits in this age group center on contraception, immunizations, mental health issues, and "bone-headed guys who do stupid, risky stuff," Keckley says. "Relative to family coverage, it's not an expensive product."
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More
Talking PIE, the Act, Before Thanksgiving
November 23rd 2022AMCP CEO Susan A. Cantrell spoke with Managed Healthcare Executive® about Preapproval Information Exchange (PIE) Act of 2022, which would allow drug manufacturers to share information about a drug with payers before the drug is approved. Cantrell says passage of the PIE Act would speed up patient access to new medications.
Read More
Inflation Reduction Act and the Impact on Pharmaceutical Pricing and Investment Decisions
November 21st 2022The reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.
Read More